FEI Tribunal issues final decisions on two controlled medication cases at Tryon 2018

The FEI Tribunal has issued its Final Decisions on the two Controlled Medication cases in the Endurance discipline at the FEI World Equestrian Games™ Tryon 2018 (11-23 September). Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition.

The cases involve the horse Mora Inocente (FEI ID 103TG88/ARG), ridden by Pablo De Los Heros (FEI ID 10017972/ARG), which tested positive to Dexamethasone, and the horse El Pangue Ciromagnum (FEI ID 104AV29/CHI), ridden by Raimundo Undurraga Mujica (FEI ID 10063169/CHI), which tested positive to Triamcinolone Acetonide.

The FEI Tribunal accepted agreements between the FEI and the two athletes reached on 21 February 2019. The athletes were suspended for two months, starting on the date of the FEI Tribunal’s approval of the agreement in its Final Decisions on 28 February 2019. The athletes were also each fined CHF 1,500. Each of the parties will pay their own legal costs.

The athletes have 21 days to appeal the decisions to the Court of Arbitration for Sport (CAS) from the date of notification of the Final Decisions.

The FEI Tribunal’s decisions can be found here.